[HTML][HTML] Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O Van Tellingen, A Claes, LJA Stalpers… - BMC cancer, 2009 - Springer
Background The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O Tellingen, A Claes, LJA Stalpers… - BMC Cancer (Online …, 2009 - osti.gov
The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM)
should be considered in the unique context of malignant brain tumours. Although patients …
should be considered in the unique context of malignant brain tumours. Although patients …
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O Tellingen, A Claes, LJA Stalpers… - BMC Cancer …, 2009 - inis.iaea.org
[en] The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme
(GBM) should be considered in the unique context of malignant brain tumours. Although …
(GBM) should be considered in the unique context of malignant brain tumours. Although …
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O van Tellingen… - BMC …, 2009 - researchinformation.amsterdamumc …
BACKGROUND: The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
[PDF][PDF] Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O van Tellingen, A Claes, LJA Stalpers… - BMC Cancer, 2009 - dare.uva.nl
Background: The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
[HTML][HTML] Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O van Tellingen, A Claes… - BMC Cancer, 2009 - ncbi.nlm.nih.gov
Background The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O van Tellingen, A Claes… - BMC …, 2009 - search.proquest.com
Background: The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.
JJ Verhoeff, O van Tellingen, A Claes, LJ Stalpers… - BMC Cancer, 2009 - europepmc.org
Background The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
[PDF][PDF] Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O van Tellingen, A Claes… - BMC Cancer, 2009 - researchgate.net
Background: The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
JJC Verhoeff, O van Tellingen, A Claes… - BMC …, 2009 - pubmed.ncbi.nlm.nih.gov
Background The relevance of angiogenesis inhibition in the treatment of glioblastoma
multiforme (GBM) should be considered in the unique context of malignant brain tumours …
multiforme (GBM) should be considered in the unique context of malignant brain tumours …